YCBD 8-K 2026-11-04

cbdMD, Inc. (YCBD) 8-K dated 2026-11-04 — accession 0001437749-26-034991.

cbdMD, Inc. (YCBD) is a drug manufacturers - specialty & generic company listed on AMEX.

cbdMD, Inc. filed a 8-K on 2026-11-04. Accession 0001437749-26-034991.

This 8-K covers: Acquisition or disposition (Item 2.01), New debt obligation (Item 2.03), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported YCBD revenue for 2025-09-30 was $19.2M. Net income was -$2.0M. Revenue was down 1.5% from 2024-09-30 to 2025-09-30. YCBD currently screens at market cap $7.2M.

Not investment advice. The YCBD SEC hub lists recent forms. The stock page is the research view.